Monosomy 7 is the most frequent cytogenetic alteration, being present in 37–57% of all patients with GATA2 MDS and 48–72% of adolescents (>12 years old) with GATA2 MDS [22,49,76]. This evidence concerns the gene GATA2 and myelodysplastic syndrome.